TradersVenue

Sunpharma Short below 443

Short
TradersVenue Updated   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
#SunPharma has generated sell signal near 457. However 443 is an important support level for the stock. Closing below 443, it can revisit 431/408 levels. Wait for breakdown.
Comment:
Disclaimer: Objective of this channel and posts is to educate and help members learn technical analysis, from my personal trade picks. All these stock ideas or trade updates are for educational purpose only and completely non-advisory in nature. I am not a SEBI registered analyst and strongly recommend people not to trade in NSE / BSE / MCX market basis my trade ideas. These stock ideas or views shared in the channel are momentum picks chosen using technical analysis and indicators and for my own trading purpose only. Technical indicators are lagging and may generate false buy/sell signals too. Market is supreme and my views may go horribly wrong. Please don't consider these trade ideas as trading recommendations. You may consider it for learning or at max use it for paper trading. Strictly avoid it for real trading. I am not responsible for any kind of profit and losses or SEBI audits arising out of the above calls. Stock market trading and investment is subject to market risks. Contact your financial advisor before taking trades or trade at your own risk.

For live updates and trading ideas you can follow me on below social media platforms. You can also forward this channel links to others.

Tweeter: twitter.com/PrasunaBarik
TradingView.in:http://bit.ly/2J005mi
Telegram: t.me/TradersVenue
Strictly For Educational Purpose Only

For queries, suggestions, access requests you can reach out to me using below social media handles.

EMail_ID:- support@tradersvenue.com
Telegram: t.me/TradersVenue
Twitter: twitter.com/PB_Fin
YouTube: www.youtube.com/channel
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.